Purpose of Review: Maternal hypertension is a common and serious condition associated with increased maternal and foetal morbidity and mortality, with early detection and management improving outcomes. Recent Findings: Blood pressure (BP) changes of pre-eclampsia are defined after 20 gestational weeks, while haemodynamic changes can be detected at 5–11 weeks using a specialised non-invasive Doppler stroke volume (SV) monitor. Thus, advanced haemodynamic monitoring allows for physiologically precise identification of circulatory abnormalities, and implementation of appropriate therapy within the first trimester. We measured the oscillometric BP and advanced haemodynamics (USCOM 1A) of 3 unselected women with singleton pregnancies, consecutively listed for therapeutic induction for maternal hypertension at 32–41 weeks gestational age. While the BP’s of the patients varied, it was the haemodynamics, particularly SV, cardiac output, systemic vascular resistance, Smith Madigan Inotropy Index, and oxygen deliver, that identified differing patterns of circulatory dysfunction, therapeutic objectives, and predicted post-partum complications of the mother and child. Summary: First trimester screening of maternal haemodynamics may allow for earlier detection of circulatory derangements, selection of patient precise interventions, and improved maternal-foetal outcomes.
Central blood pressure (cBP) is known to be a better predictor of the damage caused by hypertension in comparison with peripheral blood pressure. During cardiac catheterization, we measured cBP in the ascending aorta with a fluid-filled guiding catheter (FF) in 75 patients and with a high-fidelity micromanometer tipped wire (FFR) in 20 patients. The wire was withdrawn into the brachial artery and aorto-brachial pulse wave velocity (abPWV) was calculated from the length of the pullback and the time delay between the ascending aorta and the brachial artery pulse waves by gating to the R-wave of the ECG for both measurements. In 23 patients, a cuff was inflated around the calf and an aorta-tibial pulse wave velocity (atPWV) was calculated from the distance between the cuff around the leg and the axillary notch and the time delay between the ascending aorta and the tibial pulse waves. Brachial BP was measured non-invasively and cBP was estimated using a new suprasystolic oscillometric technology. The mean differences between invasively measured cBP by FFR and non-invasive estimation were −0.4 ± 5.7 mmHg and by FF 5.4 ± 9.4 mmHg in 52 patients. Diastolic and mean cBP were both overestimated by oscillometry, with mean differences of −8.9 ± 5.5 mmHg and −6.4 ± 5.1 mmHg compared with the FFR and −10.6 ± 6.3 mmHg and −5.9 ± 6.2 mmHg with the FF. Non-invasive systolic cBP compared accurately with the high-fidelity FFR measurements, demonstrating a low bias (≤5 mmHg) and high precision (SD ≤ 8 mmHg). These criteria were not met when using the FF measurements. Invasively derived average Ao-brachial abPWV was 7.0 ± 1.4 m/s and that of Ao-tibial atPWV was 9.1 ± 1.8 m/s. Non-invasively estimated PWV based on the reflected wave transit time did not correlate with abPWV or with atPWV. In conclusion, we demonstrate the advantages of a novel method of validation for non-invasive cBP monitoring devices using acknowledged gold standard FFR wire transducers and the possibility to easily measure PWV during coronary angiography with the impact of cardiovascular risk factors.
Background: Hypertension (HTN) is an elevated blood pressure (BP) compared to normative data. However, physiologically it is a product of the central haemodynamic variables of stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR) (BP = (SV x HR) x SVR). Multiple global clinical guidelines recommend anti-hypertensive therapy to reduce BP, yet effective BP control of people diagnosed with HTN remains persistently dismal at ~25% while central haemodynamics are ignored. BP is a cornerstone of HTN practice, yet is an insensitive measure of circulation and sheds little light on the critical therapeutic central haemodynamic variables of SV, CO and SVR, and ultimately may limit our understanding of the pathophysiology of HTN and its management. Methods: Word searches were conducted on Australian, Canadian, Chinese, European, Japanese, Singaporean, UK, US and International hypertension guidelines using the Adobe or Microsoft word count function, with specific searches made for BP, and central haemodynamic parameters, and the results tabulated. Results: A total of 695 pages and 478,537 words were published in nine HTN guidelines by representative global organisations, with BP parameters mentioned 7,535 times, and central haemodynamic parameters mentioned 47 times. All guidelines recommended BP target values and pressure-led therapies, while no central haemodynamic targets were noted. Conclusions: Although physiologically core to the aetiology and treatment of HTN, central haemodyanmic parameters are ignored in current practice guidelines. Poor global outcomes suggest the inclusion of central haemodynamics in everyday practice may improve our understanding of HTN and facilitate the delivery of precise anti-hypertensive therapy.
9 February 2006 in The Thoracic and Cardiovascular Surgeon
Aims: Cardiac output (CO) and systemic vascular resistance (SVR) are important haemodynamic parameters in emergency patients and for clinical early goal directed therapy. This study evaluated the feasibility of early CO and SVR determination using preclinical ultrasound in a helicopter air medical service (HEMS) on emergency patients presenting with or without thoracic pain as a pilot observational study. Methods: 44 consecutive emergency patients (62.8±22yrs, 23 males) were classified preclinically as with (15 patients, 69±14yrs, 40% male) or without (29 patients, 60±25yrs, 59% male) thoracic pain. Haemodynamic parameters were determined based on continuous wave Doppler non-invasively (USCOM, Sydney, Australia): stroke volume (SV), CO, cardiac index (CI), and SVR. HEMS service in Germany was physician based with one experienced examiner doing all ultrasound scans. Results: Non-invasive SV, CO, CI and SVR determination is feasible using preclinical ultrasound in HEMS. Thoracic pain patients had higher SVR (2709±891 vs. 1499±661 dyne*s*cm-5) and lower CO/CI (3.37±1.1 vs. 5.06±2.9 l/min, CI: 1.67±0.58 vs. 3.18±1.34 l/min/m2) than patients without thoracic pain. Highest cardiac outputs were measured during and after seizures (n=6, 7.5±3.05 l/min). The range of CO measured in 6 cardiopulmonary resuscitation patients was 2.7 to 12 l/min, the level of CO not associated with the establishing of sustained circulation. Conclusion: It is feasible to determine stroke volume, CO/CI and SVR in different emergency situations in HEMS. Thoracic pain has increased SVR and lower CO/CI than non-thoracic pain patients. CO/CI and SVR may help in early goal directed therapy in preclinical medicine in thoracic pain patients. However, further preclinical outcome studies are warranted.